Bio-Rad Laboratories Debt Issuance/Retirement Net - Total 2010-2025 | BIO

Bio-Rad Laboratories annual/quarterly debt issuance/retirement net - total history and growth rate from 2010 to 2025. Debt issuance/retirement net - total can be defined as the total amount of short term and long term borrowings repaid and issued.
  • Bio-Rad Laboratories debt issuance/retirement net - total for the quarter ending March 31, 2025 was $0.000B, a 50% decline year-over-year.
  • Bio-Rad Laboratories debt issuance/retirement net - total for the twelve months ending March 31, 2025 was $-0.001B, a 14.45% decline year-over-year.
  • Bio-Rad Laboratories annual debt issuance/retirement net - total for 2024 was $-0B, a 20% decline from 2023.
  • Bio-Rad Laboratories annual debt issuance/retirement net - total for 2023 was $-0.001B, a 100.04% decline from 2022.
  • Bio-Rad Laboratories annual debt issuance/retirement net - total for 2022 was $1.186B, a 39361.59% decline from 2021.
Bio-Rad Laboratories Annual Debt Issuance/Retirement Net - Total
(Millions of US $)
2024 $0
2023 $-1
2022 $1,186
2021 $-3
2020 $-427
2019 $-1
2018 $-3
2017 $0
2016 $0
2015 $0
2014 $-2
2013 $-300
2012 $-1
2011 $-231
2010 $217
2009 $286
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $6.647B $2.567B
Bio-Rad Laboratories is a manufacturer and global supplier of clinical diagnostics and life science research products in the healthcare, analytical chemistry life science research and other markets. It offers a wide portfolio of products and systems which allow the separation of complex chemical and biological materials and discovery, analysis and purification of their components. Bio-Rad has extensive and direct distribution channels outside the United States through subsidiaries which focus on sales, customer service and product distribution. The company operates through two reportable segments - Life Science segment which designs, manufactures, markets and services reagents, apparatus and instruments utilized for biological research. Clinical Diagnostics - This business markets and distributes products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians office laboratories, transfusion laboratories as well as insurance and forensic testing laboratories.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $216.470B 25.39
Boston Scientific (BSX) United States $153.537B 38.44
Stryker (SYK) United States $147.836B 30.91
EssilorLuxottica (ESLOY) France $131.607B 0.00
Medtronic (MDT) Ireland $115.044B 16.31
Lonza Group Ag (LZAGY) Switzerland $49.188B 0.00
Haleon (HLN) United Kingdom $42.812B 24.44
ResMed (RMD) United States $38.280B 28.75
GE HealthCare Technologies (GEHC) United States $33.957B 16.12
Agilent Technologies (A) United States $31.827B 20.75
Terumo (TRUMY) Japan $24.178B 31.40
Koninklijke Philips (PHG) Netherlands $23.630B 16.58
Insulet (PODD) United States $19.773B 77.61
Zimmer Biomet Holdings (ZBH) United States $18.319B 11.77
Baxter (BAX) United States $14.046B 10.49
Smith & Nephew SNATS (SNN) United Kingdom $13.262B 0.00
Sunny Optical Technology (SNPTF) China $10.417B 0.00
Demant (WILYY) Denmark $8.633B 0.00
Lantheus Holdings (LNTH) United States $4.951B 12.49
Prestige Consumer Healthcare (PBH) United States $3.734B 16.68
Perrigo (PRGO) Ireland $3.704B 9.39
Haemonetics (HAE) United States $3.544B 16.14
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Envista Holdings (NVST) United States $3.300B 27.42
ICU Medical (ICUI) United States $2.994B 22.08
LeMaitre Vascular (LMAT) United States $1.803B 40.31
QuidelOrtho (QDEL) United States $1.711B 11.77
AtriCure (ATRC) United States $1.448B 0.00
Acuren (TIC) United States $1.408B 0.00
Green Thumb Industries (GTBIF) United States $1.251B 28.13
AdaptHealth (AHCO) United States $1.235B 12.53
Phibro Animal Health (PAHC) United States $1.181B 15.10
Neogen (NEOG) United States $1.037B 13.28
BioLife Solutions (BLFS) United States $0.993B 0.00
InMode (INMD) Israel $0.882B 8.89
Kestra Medical Technologies (KMTS) United States $0.854B 0.00
Curaleaf Holdings (CURLF) Canada $0.831B 0.00
Tilray Brands (TLRY) Canada $0.678B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.606B 0.00
Owens & Minor (OMI) United States $0.598B 4.96
Evolus (EOLS) United States $0.594B 0.00
CeriBell (CBLL) United States $0.550B 0.00
Valneva SE (VALN) France $0.540B 0.00
ZimVie (ZIMV) United States $0.522B 23.75
Surmodics (SRDX) United States $0.446B 0.00
SNDL (SNDL) Canada $0.415B 0.00
Sanuwave Health (SNWV) United States $0.328B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.315B 0.00
VAREX IMAGING (VREX) United States $0.305B 11.22
Cresco Labs (CRLBF) United States $0.302B 0.00
Capricor Therapeutics (CAPR) United States $0.286B 0.00
Aurora Cannabis (ACB) Canada $0.264B 78.33
Cerus (CERS) United States $0.264B 0.00
Quanterix (QTRX) United States $0.259B 0.00
Viemed Healthcare (VMD) United States $0.256B 21.57
OraSure Technologies (OSUR) United States $0.243B 0.00
Sanara MedTech (SMTI) United States $0.234B 0.00
Canopy Growth (CGC) Canada $0.230B 0.00
Brainsway (BWAY) Israel $0.228B 60.45
Biote (BTMD) United States $0.219B 6.17
Verano Holdings (VRNOF) United States $0.213B 0.00
Omeros (OMER) United States $0.213B 0.00
Organigram Global (OGI) Canada $0.196B 0.00
High Tide (HITI) Canada $0.194B 0.00
Utah Medical Products (UTMD) United States $0.180B 14.70
TriSalus Life Sciences (TLSI) United States $0.173B 0.00
Vireo Growth (VREOF) United States $0.151B 0.00
Exagen (XGN) United States $0.148B 0.00
FitLife Brands (FTLF) United States $0.122B 14.99
TerrAscend (TSNDF) Canada $0.121B 0.00
Jin Medical (ZJYL) China $0.101B 0.00
Fonar (FONR) United States $0.099B 12.82
MacroGenics (MGNX) United States $0.093B 0.00
Quipt Home Medical (QIPT) United States $0.088B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.087B 0.00
Veru (VERU) United States $0.085B 0.00
Jushi Holdings (JUSHF) United States $0.085B 0.00
Apyx Medical (APYX) United States $0.085B 0.00
Safety Shot (SHOT) United States $0.075B 0.00
InterCure (INCR) Israel $0.072B 0.00
Zynex (ZYXI) United States $0.071B 0.00
Cytosorbents (CTSO) United States $0.065B 0.00
Agape ATP (ATPC) $0.065B 0.00
ImmuCell (ICCC) United States $0.062B 0.00
United-Guardian (UG) United States $0.043B 14.87
Rockwell Medical (RMTI) United States $0.038B 0.00
Modular Medical (MODD) United States $0.038B 0.00
Nephros (NEPH) United States $0.038B 51.00
Allurion Technologies (ALUR) United States $0.024B 0.00
INLIF (INLF) $0.015B 0.00
Flora Growth (FLGC) United States $0.015B 0.00
Meihua Medical Technologies (MHUA) China $0.014B 0.00
Trinity Biotech (TRIB) Ireland $0.013B 0.00
IM Cannabis (IMCC) Canada $0.012B 0.00
Senestech (SNES) United States $0.010B 0.00
Cellectar Biosciences (CLRB) United States $0.009B 0.00
Innovative Eyewear (LUCY) United States $0.007B 0.00
Sharps Technology (STSS) United States $0.006B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
Akanda (AKAN) Canada $0.002B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00